APA (7th ed.) Citation

WJ, H., K, N., CC, N., TW, H., P, P., SW, K., . . . H, Y. (2026). Eptinezumab in treatment-resistant chronic migraine: Four-year real-world effectiveness and treatment persistence. Cephalalgia : an international journal of headache, 46(5), 3331024261451427. https://doi.org/10.1177/03331024261451427

Chicago Style (17th ed.) Citation

WJ, Hsieh, Nicol K, Ng CC, Hou TW, Phan P, Keith SW, Heckel B, Marmura MJ, and Yuan H. "Eptinezumab in Treatment-resistant Chronic Migraine: Four-year Real-world Effectiveness and Treatment Persistence." Cephalalgia : An International Journal of Headache 46, no. 5 (2026): 3331024261451427. https://doi.org/10.1177/03331024261451427.

MLA (9th ed.) Citation

WJ, Hsieh, et al. "Eptinezumab in Treatment-resistant Chronic Migraine: Four-year Real-world Effectiveness and Treatment Persistence." Cephalalgia : An International Journal of Headache, vol. 46, no. 5, 2026, p. 3331024261451427, https://doi.org/10.1177/03331024261451427.